INGN · Inogen Inc
$5.75
-0.06 (-1.03%)
At close · Aug 14
Market Cap
$152.60M
Shares
26.54M
Inogen Inc Earnings Call Transcripts
Every quarterly earnings call for Inogen Inc (INGN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲13.2%
$105.39M
−$9.51M
'22 Q3
22-11-02
▲15.3%
$88.09M
−$56.61M
'22 Q4
23-02-23
▼10.2%
$72.16M
−$20.35M
'23 Q1
23-05-04
▼19.1%
$83.64M
−$9.83M
'23 Q2
23-07-13
▼20.3%
$83.97M
−$45.72M
'23 Q3
23-11-07
▼13.8%
$75.90M
−$26.55M
'23 Q4
24-02-27
▲8.1%
$78.03M
−$14.58M
'24 Q1
24-05-07
▲6.1%
$88.77M
−$5.59M
'24 Q2
24-08-06
▲5.8%
$88.83M
−$5.96M
'24 Q3
24-11-07
▲5.5%
$80.08M
−$9.76M
'24 Q4
25-01-13
▲5.5%
$82.28M
−$6.17M
'25 Q1
25-05-07
▲4%
$92.28M
−$4.15M
'25 Q2
25-08-07
▲4%
$92.39M
−$5.29M
'25 Q3
25-11-05
▲2%
$81.72M
−$7.13M
'25 Q4
26-02-24
▲3.4%
$85.11M
−$8.32M
'26 Q1
26-05-07
LATEST
▲3%
$95.08M
−$3.85M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Inogen Inc Q2 FY2026 Earnings Call
Positive tone
International growth
New product launches (Aurora)
Profitability and cost review
Revenue
$95.08M
▲ 3% YoY Diluted EPS
$-0.14
Gross margin
45.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Inogen Inc Q1 FY2026 Earnings Call
Positive tone
Q1 financial results
International expansion
Aurora CPAP mask launch
Revenue
$85.11M
▲ 3.4% YoY Diluted EPS
$-0.30
Gross margin
44.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-14
25th Annual Needham Virtual Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-24
Inogen Inc Q4 FY2025 Earnings Call
Confident tone
SemiOx Airway Clearance Device
Innovation Pipeline and Product Portfolio Diversification
International Expansion
Revenue
$81.72M*
▲ 2% YoY Gross margin
43.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Inogen Inc Q3 FY2025 Earnings Call
Confident tone
Simeox commercialization
Gross margin pressure
Voxi 5 product launch
Revenue
$92.39M
▲ 4% YoY Diluted EPS
$-0.20
Gross margin
44.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Inogen Inc Q2 FY2025 Earnings Call
Confident tone
Innovation pipeline and product launches
Path to profitability and adjusted EBITDA
POC market conversion opportunity
Revenue
$92.28M
▲ 4% YoY Diluted EPS
$-0.15
Gross margin
44.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Inogen Inc Q1 FY2025 Earnings Call
Positive tone
B2B channel growth
Tariff impact and exemptions
DTC channel headwinds
Revenue
$82.28M
▲ 5.5% YoY Diluted EPS
$-0.25
Gross margin
44.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-13
Inogen Inc Q4 FY2024 Earnings Call
Positive tone
Simeox airway clearance device
Yuwell collaboration and investment
Medicare reimbursement and payor strategy
Revenue
$80.08M*
▲ 5.5% YoY Gross margin
45.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Inogen Inc Q3 FY2024 Earnings Call
Positive tone
Innovation Pipeline
Path to Profitability
Direct-to-Consumer Headwinds
Revenue
$88.83M
▲ 5.8% YoY Diluted EPS
$-0.25
Gross margin
46.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Inogen Inc Q2 FY2024 Earnings Call
Positive tone
Hospital and patient-first pilots
B2B growth
Guidance and outlook
Revenue
$88.77M
▲ 6.1% YoY Diluted EPS
$-0.24
Gross margin
48.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Inogen Inc Q1 FY2024 Earnings Call
Positive tone
Gross margin and COGS
Business-to-business channels (domestic and international)
Rental channel and hospital strategy
Revenue
$78.03M
▲ 8.1% YoY Diluted EPS
$-0.62
Gross margin
44.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Inogen Inc Q4 FY2023 Earnings Call
Balanced tone
New leadership and organization
Channel strategy and restructuring
PhysioAssist / Simeox regulatory clearance
Revenue
$75.90M*
▼ 13.8% YoY Gross margin
37.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Inogen Inc Q3 FY2023 Earnings Call
Revenue
$83.97M
▼ 20.3% YoY Diluted EPS
$-1.97
Gross margin
40.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-13
Inogen Inc Q2 FY2023 Earnings Call
Revenue
$83.64M
▼ 19.1% YoY Diluted EPS
$-0.42
Gross margin
40.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Inogen Inc Q1 FY2023 Earnings Call
Revenue
$72.16M
▼ 10.2% YoY Diluted EPS
$-0.88
Gross margin
42.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Inogen Inc Q4 FY2022 Earnings Call
Revenue
$88.09M*
▲ 15.3% YoY Gross margin
33.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Inogen Inc Q3 FY2022 Earnings Call
Revenue
$105.39M
▲ 13.2% YoY Diluted EPS
$-0.42
▼ 179.2% YoY Gross margin
40.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Inogen Inc Q2 FY2022 Earnings Call
Revenue
$103.38M
▲ 1.8% YoY Diluted EPS
$-0.15
▼ 168.2% YoY Gross margin
44.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Inogen Inc Q1 FY2022 Earnings Call
Revenue
$80.39M
▼ 7.5% YoY Diluted EPS
$-0.62
Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Inogen Inc Q4 FY2021 Earnings Call
Revenue
$76.40M*
▲ 3.3% YoY Gross margin
50.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Inogen Inc Q3 FY2021 Earnings Call
Revenue
$93.11M
▲ 25.3% YoY Diluted EPS
$0.53
Gross margin
51.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Inogen Inc Q2 FY2021 Earnings Call
Revenue
$101.56M
▲ 41.7% YoY Diluted EPS
$0.22
▲ 83.3% YoY Gross margin
49.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Inogen Inc Q1 FY2021 Earnings Call
Revenue
$86.93M
▼ 1.8% YoY Diluted EPS
$-0.03
Gross margin
45.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Inogen Inc Q4 FY2020 Earnings Call
Revenue
$73.98M
▼ 6.3% YoY Diluted EPS
$-0.23
Gross margin
46.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
Inogen Inc Q3 FY2020 Earnings Call
Revenue
$74.33M
▼ 19% YoY Diluted EPS
$-0.08
▼ 125.8% YoY Gross margin
44.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Inogen Inc Q2 FY2020 Earnings Call
Revenue
$71.69M
▼ 29.1% YoY Diluted EPS
$0.12
▼ 73.3% YoY Gross margin
45.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Inogen Inc Q1 FY2020 Earnings Call
Revenue
$88.49M
▼ 1.9% YoY Diluted EPS
$-0.07
▼ 129.2% YoY Gross margin
43.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Inogen Inc Q4 FY2019 Earnings Call
Revenue
$78.92M
▼ 8.8% YoY Diluted EPS
$-0.06
▼ 113.6% YoY Gross margin
43.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 earnings calls
Key facts
CIK
1294133
CUSIP
45780L104
13F (30d)
120 filings
119 filers
Visit website
Investor relations